Colonic Neoplasms: all 1,485 studies
Page 5 of 15. Open to participants first (362), then studies with results posted, then the rest; newest registration first within each.
- Prehabilitation of Frail Surgical Cancer Patients Using Remote Ischemic PreconditioningCompletedNCT03853473Not applicableResults posted
- Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal CancersCompletedNCT03801915Phase 2Results posted
- Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE TrialTerminatedNCT03765736Results posted
- Stoma Closure and Reinforcement TrialCompletedNCT03750461Not applicableResults posted
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 PatientsTerminatedNCT03745326Phase 1/2Results posted
- Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal CancerCompletedNCT03711058Phase 1/2Results posted
- Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal CancerTerminatedNCT03592641Phase 2Results posted
- Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing TreatmentActive, not recruitingNCT03516942Results posted
- A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC)TerminatedNCT03449030Phase 1Results posted
- Palbociclib and Cetuximab in Metastatic Colorectal CancerCompletedNCT03446157Phase 2Results posted
- PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRCCompletedNCT03442569Phase 2Results posted
- M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite InstabilityCompletedNCT03436563Phase 1/2Results posted
- Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon CancerCompletedNCT03428126Phase 2Results posted
- A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary CareCompletedNCT03407417Not applicableResults posted
- Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced CancerCompletedNCT03384316Phase 1Results posted
- S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT03365882Phase 2Results posted
- Project HERO: Health Empowerment & Recovery OutcomesCompletedNCT03345563Not applicableResults posted
- Water Immersion and Polyp Detection: A Randomized Controlled TrialCompletedNCT03231917Not applicableResults posted
- A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Active, not recruitingNCT03157128Phase 1/2Results posted
- Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerCompletedNCT03154190Not applicableResults posted
- QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing CancerTerminatedNCT03127098Phase 1/2Results posted
- Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsCompletedNCT03037385Phase 1/2Results posted
- Patient Satisfaction With Propofol for Out Patient ColonoscopyCompletedNCT02937506Phase 4Results posted
- Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairActive, not recruitingNCT02912559Phase 3Results posted
- Pembrolizumab + Poly-ICLC in MRP Colon CancerCompletedNCT02834052Phase 1/2Results posted
- Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon CancerCompletedNCT02792842Phase 2Results posted
- A Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsTerminatedNCT02784795Phase 1Results posted
- S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal CancerCompletedNCT02728804Results posted
- Comparison of Colon Adenoma Detection Rate Using Two Distal Colonoscope AttachmentsCompletedNCT02665741Not applicableResults posted
- A ProspectiveTrial Comparing THUNDERBEAT to the Ligasure Energy Device During Laparoscopic Colon SurgeryCompletedNCT02628093Not applicableResults posted
- Trial Comparing Transversus Abdominis Plane Block Versus Epidural Anesthesia for Pain Management in Colorectal SurgeryCompletedNCT02591407Not applicableResults posted
- L-Menthol Injection as a Novel Technique During ColonoscopyTerminatedNCT02588248Phase 3Results posted
- Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based ChemotherapyCompletedNCT02569723Not applicableResults posted
- Evaluating Strategies to Present Colon Cancer Screening InformationCompletedNCT02485561Not applicableResults posted
- Adjuvant Aspirin Treatment for Colon Cancer PatientsTerminatedNCT02467582Phase 3Results posted
- Developing an mHealth Application to Improve Cancer Chemotherapy Symptom ManagementCompletedNCT02460822Not applicableResults posted
- Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal CancerCompletedNCT02393755Phase 1/2Results posted
- Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal CancerCompletedNCT02368886Phase 2Results posted
- End-of-Life Care for African AmericansCompletedNCT02320123Not applicableResults posted
- Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerActive, not recruitingNCT02293954Not applicableResults posted
- Vitamin D and Screening Colonoscopy or Polyp SurveillanceCompletedNCT02269332Results posted
- Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal CancerCompletedNCT02138617Phase 2Results posted
- Glucagon Use in ColonoscopiesCompletedNCT02078726Phase 4Results posted
- Genistein in Treatment of Metastatic Colorectal CancerCompletedNCT01985763Phase 1/2Results posted
- Polyp Detection With the EndoRings™: A Randomized Tandem Colonoscopy StudyCompletedNCT01955122Not applicableResults posted
- Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC)CompletedNCT01902953Phase 2Results posted
- 2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal CancerCompletedNCT01821105Phase 2Results posted
- Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With BevacizumabCompletedNCT01814501Phase 2Results posted
- PET-MRI in Diagnosing Patients With Colon or Rectal CancerCompletedNCT01807117Not applicableResults posted
- 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
- Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by SurgeryCompletedNCT01802320Phase 2Results posted
- A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon CancerCompletedNCT01744340Phase 1/2Results posted
- A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal CancerTerminatedNCT01729923Phase 2Results posted
- Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)Active, not recruitingNCT01696981Not applicableResults posted
- PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon CancerCompletedNCT01681472Phase 1/2Results posted
- Reducing VA No-Shows: Evaluation of Predictive Overbooking Applied to ColonoscopyCompletedNCT01639443Not applicableResults posted
- Polyphenon E in Treating Patients With High-Risk of Colorectal CancerTerminatedNCT01606124Phase 2Results posted
- Narrow-Band Imaging Versus Standard White Light for the Detection of Serrated Lesions in the Proximal ColonCompletedNCT01572428Not applicableResults posted
- Perfusion Assessment in Laparoscopic Left Anterior ResectionCompletedNCT01560377Phase 1Results posted
- Compare Preperitoneal Analgesia to Epidural Analgesia for Pain Control After Colon and Rectal SurgeryCompletedNCT01552226Not applicableResults posted
- Yoga and Bolus Lukewarm Saline as Rapid Colonoscopy PreparationCompletedNCT01547130Phase 1/2Results posted
- Comparing Water Immersion and Water Exchange Methods During Minimally Sedated ColonoscopyCompletedNCT01535326Not applicableResults posted
- Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver MetastasesCompletedNCT01528878Not applicableResults posted
- Cancer Vaccine Targeting Brachyury Protein in TumorsCompletedNCT01519817Phase 1Results posted
- Randomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver MetastasesTerminatedNCT01505166Phase 2Results posted
- Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)TerminatedNCT01464593Phase 2Results posted
- Fluorescent Evaluation of Colorectal AnastamosesCompletedNCT01424293Not applicableResults posted
- Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaCompletedNCT01394939Phase 1/2Results posted
- Phase 1b Dose Escalation Study of Intravenous JX-594 in Metastatic, Refractory Colorectal CarcinomaCompletedNCT01380600Phase 1Results posted
- Linifanib in Treating Patients With Advanced, Refractory Colorectal CancerTerminatedNCT01365910Phase 2Results posted
- Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)CompletedNCT01363843Phase 2Results posted
- Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary CareCompletedNCT01346839Not applicableResults posted
- Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic ResectionCompletedNCT01339273Not applicableResults posted
- Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had ChemotherapyTerminatedNCT01339000Phase 2Results posted
- Neoadjuvant Recombinant Vaccinia Virus for Metastatic Colorectal Cancer With Liver ResectionTerminatedNCT01329809Phase 2Results posted
- A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRITerminatedNCT01322815Phase 2Results posted
- Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal CancerTerminatedNCT01320683Phase 2Results posted
- Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal CancerTerminatedNCT01285102Phase 1Results posted
- Effect of Celecoxib on Perioperative Inflammatory Response in Colon CancerTerminatedNCT01284504Not applicableResults posted
- Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening ColonoscopyCompletedNCT01170754Phase 4Results posted
- A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum.CompletedNCT01169558Phase 3Results posted
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With SurgeryCompletedNCT01150045Phase 3Results posted
- Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon CancersTerminatedNCT01149434Phase 1/2Results posted
- QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEACompletedNCT01147965Phase 1/2Results posted
- RO4929097 in Treating Patients With Metastatic Colorectal CancerCompletedNCT01116687Phase 2Results posted
- Clinical and Translational Study of STA-9090CompletedNCT01111838Phase 2Results posted
- Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal CancerCompletedNCT01105377Phase 2Results posted
- Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI DisordersCompletedNCT01099111Results posted
- NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal SurgeryCompletedNCT01056913Phase 4Results posted
- Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With CancerCompletedNCT01037790Phase 2Results posted
- Study of Pazopanib and Ixabepilone in Patients With Solid TumorsTerminatedNCT01012362Phase 1Results posted
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By SurgeryTerminatedNCT01011478Phase 3Results posted
- Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous TreatmentCompletedNCT00942266Phase 2Results posted
- Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and BevacizumabCompletedNCT00932438Phase 1/2Results posted
- Exploratory Study Of The ERCC-1 GeneCompletedNCT00846482Not applicableResults posted
- A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and BevacizumabTerminatedNCT00845039Phase 2Results posted
- Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by SurgeryTerminatedNCT00835679Early Phase 1Results posted
- Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon CancerTerminatedNCT00826800Not applicableResults posted
- Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal CancerCompletedNCT00826540Phase 2Results posted
- PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) TumorsCompletedNCT00819780Phase 2Results posted